Soleno Therapeutics Stock Price on December 5, 2024
| SLNO Stock | USD 47.07 2.30 5.14% |
Below is the normalized historical share price chart for Soleno Therapeutics extending back to November 13, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Soleno Therapeutics stands at 47.07, as last reported on the 27th of December, with the highest price reaching 47.14 and the lowest price hitting 44.17 during the day.
If you're considering investing in Soleno Stock, it is important to understand the factors that can impact its price. Soleno Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0259, which indicates the firm had a -0.0259% return per unit of risk over the last 3 months. Soleno Therapeutics exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Soleno Therapeutics' Semi Deviation of 2.32, risk adjusted performance of 0.0198, and Coefficient Of Variation of 6292.39 to confirm the risk estimate we provide.
At this time, Soleno Therapeutics' Stock Based Compensation is very stable compared to the past year. . At this time, Soleno Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 27th of December 2024, Price Earnings To Growth Ratio is likely to grow to 7.21, though Price To Sales Ratio is likely to grow to (0.01). Soleno Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of November 2014 | 200 Day MA 47.1379 | 50 Day MA 52.5195 | Beta (1.44) |
Soleno |
Sharpe Ratio = -0.0259
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SLNO |
Estimated Market Risk
| 2.85 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Soleno Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Soleno Therapeutics by adding Soleno Therapeutics to a well-diversified portfolio.
Price Book 7.2927 | Book Value 6.45 | Enterprise Value 1.7 B | Enterprise Value Ebitda 0.0233 | Shares Float 27.5 M |
Related Headline
Annexon Headline on 5th of December 2024
Annexon to Present Phase 2 ARCHER Data on Protection of Visi... by finance.yahoo.com
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity Pivotal Phase 3 ARCHER II in GA Actively Enrolling with Data Expected Second Half 2026 BRISBANE, Calif., Dec. 05, 2024 -- Annexon, Inc. , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical co
Soleno Therapeutics Valuation on December 5, 2024
It is possible to determine the worth of Soleno Therapeutics on a given historical date. On December 5, 2024 Soleno was worth 50.03 at the beginning of the trading date compared to the closed value of 49.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Soleno Therapeutics stock. Still, in general, we apply an absolute valuation method to find Soleno Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Soleno Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Soleno Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 51.66 | 52.42 | 50.49 | 50.67 | 604,041 | |
12/05/2024 | 50.03 | 50.65 | 48.81 | 49.65 | 662,500 |
| 49.65 | 50.00 | 48.76 | 49.15 | 515,131 |
| Backtest Soleno Therapeutics | | | Soleno Therapeutics History | | | Soleno Therapeutics Valuation | Previous | Next |
Soleno Therapeutics Trading Date Momentum on December 5, 2024
| On December 06 2024 Soleno Therapeutics was traded for 49.15 at the closing time. The top price for the day was 50.00 and the lowest listed price was 48.76 . The trading volume for the day was 515.1 K. The trading history from December 6, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 1.01% . The trading price change against the current closing price is 5.36% . |
Soleno Therapeutics Fundamentals Correlations and Trends
By evaluating Soleno Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Soleno Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Soleno financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Soleno Therapeutics Stock history
Soleno Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Soleno is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Soleno Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Soleno Therapeutics stock prices may prove useful in developing a viable investing in Soleno Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 16.5 M | 17.3 M | |
| Net Loss | -21.7 M | -22.7 M |
Soleno Therapeutics Quarterly Net Working Capital |
|
Soleno Therapeutics Stock Technical Analysis
Soleno Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Soleno Therapeutics Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Soleno Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Soleno Therapeutics December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Soleno Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Soleno Therapeutics shares will generate the highest return on investment. By undertsting and applying Soleno Therapeutics stock market strength indicators, traders can identify Soleno Therapeutics entry and exit signals to maximize returns
Soleno Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Soleno Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Soleno Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Soleno to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0198 | |||
| Jensen Alpha | 0.0028 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.047 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soleno Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Return On Assets (0.48) | Return On Equity (0.91) |
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.